Association of increased upper trunk and decreased leg fat with 2-h glucose in control and HIV-infected persons

Diabetes Care

Volumn 34, Issue 11, 2011, Pages 2448-2453

  Kosmiski, Lisa A ^a   Scherzer, Rebecca ^b,c   Heymsfield, Steven B ^d   Rimland, David ^e   Simberkoff, Michael S ^f   Sidney, Stephen ^g   Shlipak, Michael G ^b,c   Bacchetti, Peter ^b   Biggs, Mary L ^h   Grunfeld, Carl ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPAIRED GLUCOSE TOLERANCE; LEG; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SMOKING; SUBCUTANEOUS FAT; TRUNK; UPPER TRUNK; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; UNITED STATES;

ADULT; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HIV INFECTIONS; HUMANS; LEG; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; SUBCUTANEOUS FAT; TORSO; UNITED STATES;

EID: 84857083894     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0616     Document Type: Article

References (25)

1. Davidson MB, Genuth S, Fagan TF, Palangio MA. American Diabetes Association Consensus Statement on IFG and IGT. Clinical Insights in Diabetes 2007:2-3
2. Manuthu EM, Joshi MD, Lule GN, Karari E. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East Afr Med J 2008;85:10-17
3. Howard AA, Floris-Moore M, Lo Y, Arnsten JH, Fleischer N, Klein RS. Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med 2006;7:389-396 (Pubitemid 44123250)
4. Mutimura E, Stewart A, Rheeder P, Crowther NJ. Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 46:451-455 (Pubitemid 350098696)
5. Jericó C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005;28:132-137 (Pubitemid 40095795)
6. Howard AA, Floris-Moore M, Arnsten JH, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis 2005;40:1492-1499 (Pubitemid 40628638)
7. Behrens G, Dejam A, Schmidt H, et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 1999;13:F63-F70 (Pubitemid 29361082)
8. Noor MA, Lo JC, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 2001;15: F11-F18 (Pubitemid 32424384)
9. Grunfeld C, Rimland D, Gibert CL, et al. Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAMstudy. J Acquir Immune Defic Syndr 2007;46:283-290 (Pubitemid 350287354)
10. Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C. The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol 2006;163:860-869
11. Bacchetti P, Gripshover B, Grunfeld C, et al.; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005;40: 121-131 (Pubitemid 41395709)
12. Kosmiski LA, Bacchetti P, Kotler DP, et al. Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab 2008;93:216-224
13. Hoeting JA, Madigan D, Raftery AE, Volinsky CT. Bayesian model averaging: a tutorial. Stat Sci 1999;14:382-401
14. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15 (Pubitemid 29222784)
15. Grunfeld C, Saag M, Cofrancesco J Jr, et al.; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS 2010;24: 1717-1726
16. Smith NL, Barzilay JI, Shaffer D, et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002;162:209-216 (Pubitemid 34098191)
17. Abate N, Garg A, Peshock RM, Stray- Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88-98
18. Marcus MA, Murphy L, Pi-Sunyer FX, Albu JB. Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat. Metabolism 1999;48: 194-199 (Pubitemid 29072274)
19. Frederiksen L, Nielsen TL, Wraae K, et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009;94: 4010-4015
20. Snijder MB, Visser M, Dekker JM, et al.; Health ABC Study. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005;48:301-308 (Pubitemid 40543303)
21. Snijder MB, Dekker JM, Visser M, et al.; Hoorn study. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 2004;27: 372-377 (Pubitemid 38174060)
22. Gerschenson M, Kim C, Berzins B, et al. Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. J Antimicrob Chemother 2009;63: 1244-1250
23. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005;165:1179-1184 (Pubitemid 40720744)
24. Pao VY, Lee GA, Taylor S, et al. The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. AIDS 2010;24:265-270
25. Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010;51:1979-1987